Results 221 to 230 of about 257,683 (336)

Advances in Molecularly Imprinted Polymers for Bone Biomarker Detection and Therapeutic Applications

open access: yesChemistryOpen, EarlyView.
This review highlights the emerging applications of molecularly imprinted polymers (MIPs) in bone regeneration and diagnosis. MIPs facilitate osteogenic treatments by guiding stem cell differentiation and delivering bioactive molecules and enable precise detection of bone turnover biomarkers via MIP‐based sensors, offering promising strategies for next‐
Ren Yang   +8 more
wiley   +1 more source

Cyclophosphamide in Treatment of Systemic Lupus Erythematosus: 7 Years' Experience [PDF]

open access: bronze, 1973
Po‐Hao Feng   +3 more
openalex   +1 more source

Spatial transcriptomics exploration of the primary neuroblastoma microenvironment in archived FFPE samples unveils novel paracrine interactions

open access: yesThe Journal of Pathology, EarlyView.
Abstract High‐risk neuroblastomas exhibit a high degree of intratumoral heterogeneity. Single‐cell RNA sequencing has greatly improved our understanding of these tumors, but the method lacks cellular tissue context and spatial information about local signaling dynamics.
Joachim T Siaw   +10 more
wiley   +1 more source

Bilateral primary adrenal lymphoma

open access: yes
Journal of General and Family Medicine, EarlyView.
Rio Shimizu, Shogo Shirota
wiley   +1 more source

The Development of a Dynamic Electronic Health Records Database for Childhood Cancer Survivors at a Single Institution: 30 Years of Data for Clinical and Research Applications

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background/Purpose A customized Electronic Health Record (EHR)‐embedded database for a childhood cancer survivorship program has the potential to capture detailed patient, treatment, and late effects information to facilitate both clinical and research applications. Methods Epic EHR SmartForm fields were utilized to create and incorporate data
Ksenya Shliakhtsitsava   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy